NEW DELHI – With an array of new technologies including wearable technology, a new drug that uses blood to treat the condition and new stem cells to help with cognitive rehabilitation, India’s medical system is set to make strides to make stroke a treatable condition.
The country’s medical experts say there is a huge need for more advances in stroke treatment.
In fact, they have recently said that they are looking to develop the world’s first artificial intelligence-powered device to treat stroke.
“This is the future,” said Dr. Anurag Sharma, chief medical officer at the National Institute of Stroke and Related Diseases (NISRD).
“The next step is to develop new drugs that can treat stroke.”
Sharma, who has spent the past eight years working on NISRD’s Stroke Initiative, said the initiative aims to bring more innovations to the stroke rehabilitation field.
“In India, stroke patients are under tremendous pressure,” he said.
“We need to find ways to better understand their condition.
That way, we can help them achieve their goals.”
One of the challenges facing stroke patients is the need for blood vessels to be kept healthy in order to keep blood flow flowing to and from the brain.
“They need to have regular blood flow,” said Sharma.
“The more blood vessels they have, the better they will be able to do their brain activities.”
The stroke rehabilitation industry in India has been hampered by the lack of funding.
The NISYD, which has funded more than 3,000 trials in stroke, says that there are more than 7,000 patients in India who need stroke rehabilitation, and many of these patients are unable to pay.
“We have been working to get these patients to pay for their treatment,” Sharma said.
The government is also funding trials of an artificial intelligence device that uses artificial neural networks to treat patients with the disease.
The technology is called the “Acebriva Neural Network.”
The researchers say it can be used to train the AI to perform tasks that require complex cognition.
“If you can’t do that, you cannot do anything,” said Rajdeep Kumar, a researcher at NISHD who is working on the technology.
“You have to train an AI and then it learns and it becomes smarter and learns things that it has learned before.”
India’s stroke patients have been waiting for an artificial brain for years.
In the last few years, the number of patients who have been tested with the device has increased, but so far it has not been widely adopted by the medical community.
Dr. Ajoy Kishore, a neurologist at the Indian Institute of Science, Bangalore, said that although the technology could be helpful in stroke rehabilitation patients, the medical system has not developed the expertise to use it in patients.
“For patients who are suffering from stroke, they do not need to be trained,” Kishot said.
“But for patients who don’t have the need of that training, it’s a very good idea.”
Dr. Deepak Gupta, a neurosurgeon at NIMH Bangalore, who is also an assistant professor at NISTD, agreed that the technology needs to be used cautiously.
“I’m not sure how much the technology is going to help stroke patients.
They might not get any benefit in the long term,” Gupta said.
Dr Kumar said the AI technology can help the patient, but that the clinical implications are still unknown.
“The AI system is still in its infancy,” Kumar said.
He also said that while the technology will help patients recover more quickly from stroke than other types of injuries, it would take time to reach clinical trials.
“It will take time for the AI system to develop and for the trials to go forward,” Kumar added.
Sharma said the NISADD is working to find funding to bring the technology to market, but he also cautioned that it would not be a simple task.
“As we understand the condition of stroke patients, we will work with the Indian government to develop technology that can help improve the condition,” Sharma told RTE.
Sharmesh said that the NISTYD is working with other stakeholders to find new funding avenues, including philanthropic donations, private funding, and research institutes.
“I have heard that a lot of funds have come in.
It’s a good idea to take it up with the government,” Sharma added.
In the meantime, NISDSD, NIMHS, and NISDRD are working to develop a device that can be implanted in patients who do not have the right type of blood vessel.
Sharma said that it is unclear when this technology will be available, but hopes that it will be ready for use by 2020.
“Our vision is to bring this technology into patients and get them trained so they can be able use it,” Sharma noted.
“It will be in patients by 2020, and I think we can bring it to patients by 2021.”
The National Institutes of Health has set up a $6